These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8878581)

  • 21. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
    Goldstein FW
    Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae.
    Woodnutt G; Berry V
    Antimicrob Agents Chemother; 1999 Jan; 43(1):29-34. PubMed ID: 9869561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.
    Pujadas R; Escriva E; Jane J; Argimon J; Fernandez F; Fava P; Galera M; Garau J
    Antimicrob Agents Chemother; 1990 Feb; 34(2):321-5. PubMed ID: 2109579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci.
    Rodríguez-Cerrato V; Del Prado G; Huelves L; Naves P; Ruiz V; García E; Ponte C; Soriano F
    Int J Antimicrob Agents; 2010 Jun; 35(6):544-9. PubMed ID: 20303716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model.
    Parra A; Ponte C; Cenjor C; García-Calvo G; Giménez MJ; Aguilar L; Soriano F
    Antimicrob Agents Chemother; 2002 Mar; 46(3):859-62. PubMed ID: 11850273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy.
    Sime FB; Johnson A; Whalley S; Santoyo-Castelazo A; Montgomery AB; Walters KA; Lipman J; Hope WW; Roberts JA
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
    Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
    Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
    Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
    J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulsatile delivery of amoxicillin against Streptococcus pneumoniae.
    Cha R; Rybak MJ
    J Antimicrob Chemother; 2004 Dec; 54(6):1067-71. PubMed ID: 15486084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penicillin pharmacodynamics in four experimental pneumococcal infection models.
    Erlendsdottir H; Knudsen JD; Odenholt I; Cars O; Espersen F; Frimodt-Møller N; Fuursted K; Kristinsson KG; Gudmundsson S
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1078-85. PubMed ID: 11257018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacteriostatic activity and killing curves of eight antibiotics against seven strains of penicillin G-resistant pneumococci].
    Barakett V; Lesage D; Delisle F; Guidet B; Burghoffer B; Richard G; Offenstadt G; Vergez P; Petit JC
    Pathol Biol (Paris); 1992 May; 40(5):483-91. PubMed ID: 1495831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla.
    Alper CM; Doyle WJ; Seroky JT; Bluestone CD
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1889-92. PubMed ID: 8843299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice.
    Gisby J; Wightman BJ; Beale AS
    Antimicrob Agents Chemother; 1991 May; 35(5):831-6. PubMed ID: 1854164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
    Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections.
    Bantar C; Nicola F; Fernandez Canigia L; Arenoso HJ; Soutric J; Montoto M; Blanco M; Smayevsky J; Jasovich A
    J Chemother; 2000 Jun; 12(3):223-7. PubMed ID: 10877517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.